(Q43677702)

English

Outcome of reclassification of World Health Organization (WHO) class III under International Society of Nephrology-Renal Pathology Society (ISN-RPS) classification: retrospective observational study

scientific article published on 27 March 2011

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Outcome of reclassification of World Health Organization (WHO) class III under International Society of Nephrology-Renal Pathology Society (ISN-RPS) classification: retrospective observational study (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

World Health Organization

0 references

author name string

Jiwon Hwang

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Hyung Jin Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Ji-Min Oh

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Joong Kyong Ahn

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Yoo Sun Lee

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Jaejoon Lee

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Yoon-Goo Kim

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Woo-Sung Huh

8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Jinwon Seo

9

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Eun-Mi Koh

10

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Hoon-Suk Cha

11

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

publication date

27 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Rheumatology International

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1877-1884

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Prognostic factors in lupus nephritis. Contribution of renal histologic data

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-1887-X

21 January 2018

Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions.

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-1887-X

21 January 2018

Class IV-S versus class IV-G lupus nephritis: clinical and morphologic differences suggesting different pathogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-1887-X

21 January 2018

The outcome and a new ISN/RPS 2003 classification of lupus nephritis in Japanese

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-1887-X

21 January 2018

New subcategories of class IV lupus nephritis: are there clinical, histologic, and outcome differences?

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-1887-X

21 January 2018

Factors associated with poor outcomes in patients with lupus nephritis

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-1887-X

21 January 2018

Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-1887-X

21 January 2018

Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-1887-X

21 January 2018

Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-1887-X

21 January 2018

Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprine.

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-1887-X

21 January 2018

The classification of glomerulonephritis in systemic lupus erythematosus revisited

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-1887-X

21 January 2018

Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21442173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Study of lupus nephritis: its classification and the significance of subendothelial deposits

1 reference

https://pubmed.ncbi.nlm.nih.gov/21442173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome criteria for lupus nephritis trials: a critical overview

1 reference

https://pubmed.ncbi.nlm.nih.gov/21442173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only

1 reference

https://pubmed.ncbi.nlm.nih.gov/21442173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The difference between lupus nephritis class IV-G and IV-S in Koreans: focus on the response to cyclophosphamide induction treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/21442173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of renal outcome in diffuse proliferative glomerulonephritis in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/21442173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/21442173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term prognosis of diffuse lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21442173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The long-term outcome of 93 patients with proliferative lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21442173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21442173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00296-011-1887-X

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43677702&oldid=2206198835"